ArticleFrontiers in microbiology2026
Single-walled carbon nanotubes as a nano-weapons against biofilm of
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/introduction: The emergence of antimicrobial resistance in bacterial biofilms represents a growing global healthcare burden, necessitating the development of novel agents with alternative mechanisms of action. Methods: In the present study, we evaluated the antibacterial and antibiofilm potential of single-walled carbon nanotubes (SWCNTs) against Results: SWCNTs exhibited potent concentration-dependent bacteriostatic and bactericidal effects, with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 62.5 and 125 μg/mL, respectively. Zones of inhibition ranged from 14.5 ± 0.30 mm to 22.0 ± 0.57 mm across concentrations of 4-16 mg/mL ( Discussion/conclusion: These spectral changes suggest physicochemical interactions that compromised membrane stability and disrupted biofilm matrix integrity. Collectively, these findings support a proposed mechanism whereby SWCNTs exert their antibacterial effect through direct membrane perturbation, interference with biofilm extracellular polymeric substances (EPS), and inhibition of early-stage biofilm adhesion and maturation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.